aTyr Pharma (LIFE) Misses Q4 EPS by 3c

aTyr Pharma (NASDAQ: LIFE) reported Q4 EPS of ($0.31), $0.03 worse than the analyst estimate of ($0.28).

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts
• Target (TGT) Tops Q2 EPS by $1.78, Beats on Revenue; Offers FY27 EPS Guidance